Clinical Trial Update: The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the rivastigmine transdermal patch in Parkinson's disease patients with dementia or memory/thinking problems. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease with Dementia
• Parkinson Disease with Mild Cognitive Impairment

Drugs mentioned

• Exelon Patch (rivastigmine transdermal patch)

Snippet

Sponsor: University of California, San Francisco | Conditions: Parkinsons Disease With Dementia, Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems | Phase 4 | Status: COMPLETED | Results posted: 2014-02-26